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Abstract 
Reported COVID‑19 deaths in Germany are relatively low as compared to many European countries. Among the 
several explanations proposed, an early and large testing of the population was put forward. Most current debates on 
COVID‑19 focus on the differences among countries, but little attention has been given to regional differences and 
diet. The low‑death rate European countries (e.g. Austria, Baltic States, Czech Republic, Finland, Norway, Poland, Slova‑
kia) have used different quarantine and/or confinement times and methods and none have performed as many early 
tests as Germany. Among other factors that may be significant are the dietary habits. It seems that some foods largely 
used in these countries may reduce angiotensin‑converting enzyme activity or are anti‑oxidants. Among the many 
possible areas of research, it might be important to understand diet and angiotensin‑converting enzyme‑2 (ACE2) 
levels in populations with different COVID‑19 death rates since dietary interventions may be of great benefit.
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Introduction
A novel strain of human coronaviruses, the severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2), 
named by the International Committee on Taxonomy of 
Viruses (ICTV) [1], has emerged and caused an infec-
tious disease referred to as “coronavirus disease 2019” 
(COVID-19) by the World Health Organization (WHO) 
[2]. COVID-19 has aggressively spread across the globe 
and over 160,000 deaths have been reported. However, 
there appears to be high- and low-death rate countries.
After the outbreak in China, COVID-19 has also 
affected Europe after becoming a pandemic. Interestingly, 
there is large variability across European countries in 
both incidence and mortality, and most current debates 
on COVID-19 focus on the differences among countries. 
German fatalities are strikingly low as compared to many 
European countries. Among the several explanations 
proposed, an early and large testing of the population was 
put forward [3].
However, little attention has been given to regional dif-
ferences and diet [4].
Biases to be considered
According to the Johns Hopkins coronavirus resource 
center (https ://coron aviru s.jhu.edu), one of the most 
important ways of measuring the burden of COVID-19 
is mortality. However, death rates are assessed differ-
ently between countries and there are many biases that 
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are almost impossible to assess. Differences in the mor-
tality rates depend on the characteristics of the health 
care system, the reporting method, whether or not deaths 
outside the hospital have been counted and other factors, 
many of which remain unknown. Countries through-
out the world have reported very different case fatality 
ratios—the number of deaths divided by the number of 
confirmed cases—but these numbers cannot be com-
pared at all due to biases. On the other hand, for many 
countries, the methodology reporting death rates in the 
different regions is standardized across the country.
European data on death rates per million 
inhabitants
We used the Johns Hopkins coronavirus resource center 
to assess death rates at the national level (https ://coron 
aviru s.jhu.edu). The current death rate per million peo-
ple in Europe shows different trends. Germany has a low 
death rate, but Austria, the Czech Republic, Poland, Slo-
vakia, the Baltic States and Finland have similar or lower 
rates. On the other hand, Belgium, France, Italy, Spain 
and the UK have higher rates (Fig. 1).
Large differences exist when assessing death rates 
within a country. In Germany, Bavaria started the earliest 
tests but was and still is the most affected region (Fig. 2). 
Death rates per million range from 8 in Mecklenburg-
Vorpommern to 87 in Bavaria.
In Switzerland, the French and Italian speaking cantons 
have a far higher death rate than the German-speaking 
ones (Fig. 3) (Office fédéral de la santé publique, Switzer-
land, https ://www.bag.admin .ch/bag/fr/home.html).
In high-rate countries such as Spain, large variations 
also exist within the country, but the numbers range from 
115 in Murcia to over 1000 in Madrid.
Is diet partly involved in different death rates 
between countries?
Most diseases exhibit large geographical variations which 
frequently remain unexplained despite abundant research 
[5]. COVID-19 will not be an exception. Though the 
more relevant factors are likely to be seasonal variations, 
immunity, cross-immunity, intensity, timing of measures 
[6], type, onset, duration and measures of protection, 
other factors like environment or nutrition should not be 
overlooked. Obesity, a risk factor of mortality in COVID-
19, suggests the importance of nutrition [7].
The “low-rate” European countries have used different 
quarantine and/or confinement times and methods and 
Fig. 1 COVID‑19 deaths per million inhabitants in Europe (April 17, 2020). For France, deaths included hospital and extra‑hospital deaths
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none have performed as many early tests as Germany. 
Thus, although the German testing approach is very 
important [3], other factors may also be significant.
Immunity in COVID‑19 and ageing
Although there are large differences between countries 
in death rates, the age-dependent severity of COVID-19 
is similar between Asian, European and American coun-
tries. The rate of deaths is increased in the older popula-
tion. Globally, there are risk factors for death including 
obesity and type 2 diabetes.
A strong relationship between hyperglycemia, 
impaired insulin pathway, and cardiovascular disease in 
type 2 diabetes is linked to oxidative stress and inflam-
mation [8]. Lipid metabolism has an important role to 
play in obesity, diabetes and its multi-morbidities, and 
the ageing process [9]. Dietary fatty acids have a signifi-
cant role in immune responses [10].
Many foods have an antioxidant activity [11–13]. Res-
veratrol, present in many foods [14], is an inhibitor of 
MERS-Coronavirus infection [15].
Fig. 2 Regional COVID‑19 death rates per million in four European countries
Fig. 3 COVID‑19 rates in Switzerland (Office fédéral de la santé publique). Cas confirmés en laboratoire (laboratory confirmed cases), distribution 
géographique (geographical distibution), cas décédés (death rate)
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Angiotensin‑converting enzyme 2 (ACE‑2)
The angiotensin-converting enzyme (ACE2) has multi-
ple physiological roles: a negative regulator of the renin-
angiotensin system, facilitator of amino acid transport, 
and the SARS-CoV and SARS-CoV-2 receptor [16]. ACE 
converts angiotensin I to angiotensin II but ACE2 cataly-
ses the conversion of angiotensin II to angiotensin and is 
also the main entry point for coronavirus 2 into cells.
Differences between countries in ACE have been asso-
ciated with genetic patterns. The ACE D allele increased 
risk of vasculitis [17] or hypertension [18]. The ACE I/D 
polymorphism is involved in the onset of type 2 diabe-
tes [19] and might be associated with susceptibility to 
peripheral vascular diseases in the Asian population [20].
However, dietary patterns have a strong effect on ACE 
levels. A high-saturated fat diet increases ACE [21]. Many 
foods have an ACE-inhibitory activity [22–24]. Anti-
oxidant activities and ACE inhibition have been largely 
found in many foods [25]. Moreover, ACE levels in blood 
are highly and rapidly sensitive to food intake [26].
Identifying whether countries with high or low ACE 
activity have different death rates would be of great inter-
est in understanding the clinical importance of interven-
tions. However, the available evidence, in particular from 
human studies, does not seem to support the hypothesis 
that inhibitors of ACE or renin-angiotensin–aldosterone 
(ACEI/ARB) drugs increase the ACE2 expression and the 
risk of COVID-19 [27]. This might suggest that changes 
in ACE expression (inhibition/stimulation) might not be 
as relevant as previously thought and other diet-related 
changes might be more (or equally) important.
Possible interactions between diet and COVID‑19 death 
rate
Germany, Austria, Croatia, the Czech Republic, Poland, 
Slovakia, the Baltic States and German-speaking Swiss 
cantons exhibit lower COVID-19 mortality rates than 
France, Italy, Spain, and the French and Italian speaking 
Swiss cantons. Among many factors, diet differs consid-
erably between these low- or high-mortality countries.
It appears that death rates in Germany are higher in the 
two Southern Regions as well as in Saarland than else-
where. Baden-Wurttemberg and Saarland are in close 
contact with Alsace (France), and the higher infection 
rate may be due to the high cross-border traffic of the 
French. However, this was not the case for Rhineland-
Palatinate (lower death rate), possibly because the East 
Region of France was contaminated later. In addition, 
Saarland is a special case as half of the deaths, unlike in 
the other German states, occurred in only a few long-
term care facilities where a high number of people were 
infected in a short time and all deaths during the episode 
were attributed to Corona without autopsies being made. 
This potential French-based contamination does not 
apply for Bavaria (earliest German region to be contami-
nated and highest death rate). Diet differs within Ger-
many, the southern states traditionally having a higher 
fat-rich diet. Diet is not normally distributed within 
country/region, which can be an additional argument in 
favour of the uneven distribution of mortality.
Nutrition may therefore play a role in the immune 
defense against COVID-19 and may explain some of the 
differences seen in COVID-19 across Europe. It will be 
needed to test dietary differences between low and high-
rate countries. Foods with potent antioxidant or anti ACE 
activity—like uncooked or fermented cabbage [28–30]—
are largely consumed in low-death rate European coun-
tries, Korea and Taiwan, and might be considered in the 
low prevalence of deaths.
Although it is difficult to compare health systems and 
death reporting across European countries, Bulgaria, 
Greece and Romania have very low death rates. This 
might also be associated with diet since cabbage (Roma-
nia) and fermented milk (Bulgaria and Greece) are com-
mon foods. The latter food is a known ACE natural 
inhibitor [31]. Turkey, another apparently low-death rate 
country, also consumes a lot of cabbage and fermented 
milk products.
Another example may be the food supply chain. The 
increasing availability of foods from big retail is a revo-
lutionary event that has impacted crops (favouring 
those that have the best ratio of effectiveness over costs 
of production) and health at a population-size level. In 
particular, such a change in food availability has altered 
alimentary habits—promoting sugar-enriched, vitamin-
depauperated foods—and has become one of the causes 
of the obesity epidemic, especially among adolescents. 
These foods come from centralized farms in selected 
areas of the world that are distributed around the planet, 
elongating the supply chain of food. The impact of long 
supply chain of food on health is measurable by an 
increase in metabolic syndrome and insulin resistance 
[32]. Therefore, rural areas that are more prone to short 
supply food may have been able to better tolerate the 
COVID-19 pandemia, with a lower death toll. These con-
siderations may be partly involved in lower death rates in 
Southern Italy compared to the Northern part.
Conclusions
Understanding the within and between country differ-
ences in COVID-19 will be of paramount importance in 
understanding COVID-19 risk and protective factors, 
and will eventually help to control the epidemics.
We acknowledge that many factors may play a role 
in the extension and severity of COVID-19, such as 
trained immunity of the population, early and fast 
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education, rapid organization and adaptation of the hos-
pitals and the public, preparedness for pandemics and 
public hygiene. Diet represents only one of the possible 
causes of the COVID-19 epidemic and its importance 
needs to be better assessed.
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